Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
273 Leser
Artikel bewerten:
(1)

Real Endpoints Named a Fierce Healthcare Innovation Awards Winner in the Financial/Operational Solutions Category

RE Assist, a turn-key solution providing information about financial assistance for healthcare costs, wins top honors

FLORHAM PARK, NJ / ACCESSWIRE / December 4, 2024 / Real Endpoints today announces it was named a Fierce Healthcare Innovation Awards winner in the Financial/Operational Solutions category. The program highlights outstanding innovation that is driving improvements and transforming the industry.

"We are thrilled to be recognized by Fierce Healthcare as the 2024 winner for the Financial/Operational Solutions Category. We know that too many Americans struggle to pay the out-of-pocket associated with their drugs and medical procedures," says Susan Raiola, President of Real Endpoints.

RE Assist, a 2023 Fierce Healthcare Innovation finalist, leverages artificial intelligence (AI) to provide patients, caregivers, and patient support program case managers with an accurate and real-time solution to the problem of high out-of-pocket costs. The tool is underpinned by an AI Discovery engine that searches the web for national, regional, and indication-specific charitable funds and foundations. Newly identified funds are validated through a rigorous human curation process. In 2024, the number of funds tracked by RE Assist grew 25%.

RE Assist provides information on charitable foundations, their eligibility requirements, and whether funds are open (i.e., able to provide assistance) or closed (unable to provide assistance). Information is consistently displayed in a simple to understand dashboard organized by disease indication. Funds are listed in alphabetical order, and date and time stamped for transparency.

"The Innovation Awards winners showcase the organizations that have demonstrated innovative solutions that have the greatest potential to save money, engage patients or revolutionize the healthcare industry," says Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma. "We are very pleased to congratulate the winners on their accomplishments."

The expert panel of judges reviewed the hundreds of awards submissions and determined which companies demonstrated innovative technologies and services that have the potential to make the greatest impact for biotech and pharma companies.

About Real Endpoints

Real Endpoints is a boutique consulting firm focused on patient access and reimbursement. Our goal: create solutions that prepare companies for competition in the value-based economy, and more importantly, help people access medical innovations. Working collaboratively with biopharma, diagnostic and medical device companies, RE provides unique advisory services tackling a wide range of coverage and reimbursement issues, from pricing and distribution to patient support services to contracting strategies, including the evaluation, structuring, negotiating, and management of value-based contracts. RE is also developing important products to support client needs in these domains. Our first product is RE Assist, providing real time financial assistance information to patients, caregivers, and patient support case managers. For more information about Real Endpoints, visit www.realendpoints.com.

About Fierce Healthcare

Fierce Healthcare delivers healthcare news at the intersection of business and policy. Our journalists strive to bring our readers breaking industry news, exclusive interviews and thoughtfully-reported stories that offer a deeper insight on how changes in the industry impact their corner of the healthcare world. Our family includes Fierce Healthcare, Fierce Health Payer, Fierce Health IT, Fierce Hospitals, Fierce Practice Management and Fierce Health Finance. Click here to subscribe to one or all of our newsletters.

About Questex
Questex helps people live better and longer. Questex brings people together in the markets that help people live better: hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy - connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.

Contact Information

Susan Raiola
President
info@realendpoints.com
973-805-2300

.

Source: Real Endpoints



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.